SCHEMBL4650591

SCHEMBL4650591

C=CC/C(=C(/C)C(=O)O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.42
CES1 P23141 3/20 0.39
CES2 O00748 2/20 0.39
HPGD P15428 2/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
POLB P06746 2/20 0.37
MAPT P10636 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
HSD17B10 Q99714 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
CYP3A4 P08684 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11853580 1.00 AKT1 (0.42) AKT1CES1CES2HPGDALDH1A1
SCHEMBL11853575 1.00 AKT1 (0.42) AKT1CES1CES2HPGDALDH1A1
SCHEMBL3297834 0.80 AKT1 (0.44) AKT1CES1CES2HPGDALDH1A1
SCHEMBL5963007 0.80 AKT1 (0.44) AKT1CES1CES2HPGDALDH1A1
SCHEMBL1702642 0.80 AKT1 (0.44) AKT1CES1CES2HPGDALDH1A1
SCHEMBL11197184 0.79 ESR1 (0.38) AKT1CES1CES2HPGDALDH1A1
SCHEMBL11197182 0.79 ESR1 (0.38) AKT1CES1CES2HPGDALDH1A1
SCHEMBL1723672 0.79 ALDH1A1 (0.39) AKT1CES1CES2HPGDALDH1A1
SCHEMBL4064472 0.78 TSHR (0.43) AKT1CES1HPGDALDH1A1LMNA
SCHEMBL5279624 0.77 CES2 (0.50) CES1CES2MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655478-B1 PHOTOACTIVE POLYMER MATERIALS ROLIC AG (CH) 2017-06-14 EP claimed
EP-0860455-B1 Photocrosslinkable polymers ROLIC AG (CH) 2008-06-04 EP claimed
EP-0763552-B1 Curable, photoactive polymeric materials ROLIC AG (CH) 2001-09-19 EP claimed
EP-0860455-A2 Photocrosslinkable polymers Rolic AG (CH) 1998-08-26 EP claimed
EP-0763552-A2 Curable, photoactive polymeric materials Rolic AG (CH) 1997-03-19 EP claimed
EP-0324480-B1 Photopolymerizable compositions and elements for refractive index imaging DU PONT (US) 1994-04-13 EP claimed
US-12044872-B2 Method for generating alignment on top of a liquid crystal polymer material Rolic Technologies AG (CH) 2024-07-23 US disclosed
US-12012382-B2 Polymerizable liquid crystal having a carbazole core Rolic Technologies AG (CH) 2024-06-18 US disclosed
US-12006463-B2 Polymerizable liquid crystal having a quinoxaline-hydrazone core Rolic Technologies AG (CH) 2024-06-11 US disclosed
US-11952524-B2 Compositions of polymerizable liquid crystals Rolic Technologies AG (CH) 2024-04-09 US disclosed
EP-3990568-B1 NEW POLYMERIZABLE LIQUID CRYSTAL HAVING A QUINOXALINE-HYDRAZONE CORE ROLIC TECH AG (CH) 2023-11-15 EP disclosed
US-11702595-B2 Polymerizable liquid crystal Rolic Technologies AG (CH) 2023-07-18 US disclosed
EP-3126883-B1 OPTICAL DEVICES WITH PATTERNED ANISOTROPY INCORPORATING PARALLAX OPTIC ROLIC TECH AG (CH) 2023-07-12 EP disclosed
EP-0763552-B1 Curable, photoactive polymeric materials ROLIC AG (CH) 2001-09-19 EP disclosed
EP-0860455-A2 Photocrosslinkable polymers Rolic AG (CH) 1998-08-26 EP disclosed
EP-0763552-A2 Curable, photoactive polymeric materials Rolic AG (CH) 1997-03-19 EP disclosed
EP-0572900-A2 Coating and its use in a process for preparing multilayer coatings Herberts Gesellschaft mit beschränkter Haftung (DE) 1993-12-08 EP disclosed
EP-0269288-B1 INTRAOCULAR LENSES KINGSTON TECHNOLOGIES, INC. (US) 1992-02-19 EP disclosed
EP-0269288-A1 Intraocular lenses KINGSTON TECHNOLOGIES, INC. (US) 1988-06-01 EP disclosed
US-4731079-A Intraocular lenses KINGSTON TECHNOLOGIES, INC. (US) 1988-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12012382-B2 Polymerizable liquid crystal having a carbazole core FZD7, CCL11, SGK2 AKT1 1281/4885CES1 4040/4885CES2 1222/4885
US-12006463-B2 Polymerizable liquid crystal having a quinoxaline-hydrazone core AQP1, AQP4, HCN1 AKT1 3251/4885CES1 4174/4885CES2 2287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.